Buscar

07/04/2022 Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
Perez, PC, Gonzalez-Juanatey, JR, Nuche, J, Matute-Blanco, L, Serrano, I, Selles, MM, Garcia, RV, Dolz, LM, Gomez-Bueno, M, Figal, DP, Crespo-Leiro, MG, Garcia-Osuna, A, Ordonez-Llanos, J, Cuscullola, JC, Guerra, JM, Delgado, JF. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.861651. PMID:35463785. IF:3.600(Q2/5D).
22/10/2021 A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Alvarez-Garcia, J, Garcia-Osuna, A, Vives-Borras, M, Ferrero-Gregori, A, Martinez-Selles, M, Vazquez, R, Gonzalez-Juanatey, JR, Rivera, M, Segovia, J, Pascual-Figal, D, Bover, R, Bascompte, R, Delgado, J, Sepulveda, AG, Bardaji, A, Perez-Villa, F, Zamorano, JL, Crespo-Leiro, M, Sanchez, PL, Ordonez-Llanos, J, Cinca, J. A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Frontiers in Physiology. 2021; 12DOI:10.3389/fphys.2021.708890. PMID:34744758. IF:4.755(Q1/3D).
01/08/2021 Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naive and Switch Scenarios in HIV-Infected Patients
Saumoy, M, Sanchez-Quesada, JL, Ordonez-Llanos, J, Podzamczer, D. Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naive and Switch Scenarios in HIV-Infected Patients. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163456. PMID:34441755. IF:4.964(Q2/4D).
01/08/2021 Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations
Saumoy, M, Di Yacovo, S, Perez, S, Sanchez-Quesada, JL, Valdivielso, JM, Subirana, I, Imaz, A, Tiraboschi, JM, Garcia, B, Ordonez-Llanos, J, Benitez, S, Podzamczer, D, Grau, M. Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations. HIV MEDICINE. 2021; 22(7)DOI:10.1111/hiv.13093. PMID:33817938. IF:3.094(Q3/8D).
06/07/2021 Cardiac Biomarker Kinetics and Their Association With Magnetic Resonance Measures of Cardiomyocyte Integrity Following a Marathon Run: Implications for Postexercise Biomarker Testing
Aengevaeren, VL, van Kimmenade, RRJ, Ordonez-Llanos, J, Garcia-Osuna, A, Kaier, TE, Marber, M, Froeling, M, van den Berg-Faay, S, Hooijmans, MT, Monte, JR, Hopman, MTE, Strijkers, GJ, Nederveen, AJ, Bakermans, AJ, Eijsvogels, TMH. Cardiac Biomarker Kinetics and Their Association With Magnetic Resonance Measures of Cardiomyocyte Integrity Following a Marathon Run: Implications for Postexercise Biomarker Testing. Journal of the American Heart Association. 2021; 10(13)DOI:10.1161/JAHA.120.020039. PMID:34180243. IF:6.107(Q2/3D).
24/10/2025 LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review
Akyol, O, Chiang, HH, Burns, AR, Yang, CY, Woodside, DG, Sawamura, T, Sánchez-Quesada, JL, Gotto, AM, Chen, CH. LDL atherogenicity determined by size, density, oxidation, apolipoprotein(a), and electronegativity: an updated review. Frontiers in Cardiovascular Medicine. 2025; 12DOI:10.3389/fcvm.2025.1649759. PMID:41210345. IF:2.900(Q2/4D).
01/06/2025 Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV
Saumoy, M, Fernandez, A, Tiraboschi, J, Peñafiel, J, Sánchez-Quesada, JL, Vega, J, García, B, Soriano, I, Podzamczer, D, Imaz, A. Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV. HIV MEDICINE. 2025; 26(6)DOI:10.1111/hiv.70017. PMID:40130659. IF:3.200(Q2/4D).
01/11/2024 A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation
Sánchez-Quesada, JL. A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation. Clinica E Investigacion En Arteriosclerosis. 2024; 36(6)DOI:10.1016/j.arteri.2024.10.003. PMID:39542529. IF:(Q/D).
04/08/2023 Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value
Enríquez-Vázquez D., Quintanilla J.G., García-Escolano A., Couselo-Seijas M., Simón-Chica A., Lee P., Alfonso-Almazán J.M., Mahía P., Redondo-Rodríguez A., Modrego J., Ortega-Hernández A., Marcos-Alberca P., Magni R., Calvo E., Gómez-Gordo R., Yan P., La Rosa G., Bustamante-Madrión J., Pérez-García C.N., Martín-Sánchez F.J., Calvo D., de la Hera J.M., García-Torrent M.J., García-Osuna Á., Ordonez-Llanos J., Vázquez J., Pérez-Villacastín J., Pérez-Castellano N., Loew L.M., Sánchez-González J., Gómez-Garre D., Filgueiras-Rama D.. Non-invasive electromechanical assessment during atrial fibrillation identifies underlying atrial myopathy alterations with early prognostic value. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-40196-y. PMID:37542075. IF:14.700(Q1/1D).
01/07/2023 Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases
Benitez, S, Sanchez-Quesada, JL. Special Issue: New Insight into the Molecular Role of Lipids and Lipoproteins in Vascular Diseases. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(13)DOI:10.3390/ijms241310659. PMID:37445837. IF:4.900(Q1/3D).
01/12/2021 ICD shock below the detection rate therapy zone-When appropriate is inadequate
Garcia-Hernando, V, Mendez-Zurita, F, Rodriguez-Font, E, Alonso-Martin, C, Guerra-Ramos, JM, Campos-Garcia, B, Moreno-Weidmann, Z, Benedicto, AM, Vinolas, X. ICD shock below the detection rate therapy zone-When appropriate is inadequate. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 2021; 32(12)DOI:10.1111/jce.15241. PMID:34532919. IF:2.942(Q3/6D).
01/10/2021 Relationship between multimorbidity and outcomes in atrial fibrillation
Proietti, M, Esteve-Pastor, MA, Rivera-Caravaca, JM, Roldan, V, Rabadan, IR, Muniz, J, Cequier, A, Bertomeu-Martinez, V, Badimon, L, Anguita, M, Lip, GYH, Marin, F, FANTASIIA Study Investigators. Relationship between multimorbidity and outcomes in atrial fibrillation. EXPERIMENTAL GERONTOLOGY. 2021; 153DOI:10.1016/j.exger.2021.111482. PMID:34303775. IF:4.253(Q2/5D).
01/10/2022 Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart
Vilahur, G, Nguyen, PH, Badimon, L. Impact of Diabetes Mellitus on the Potential of Autologous Stem Cells and Stem Cell-Derived Microvesicles to Repair the Ischemic Heart. CARDIOVASCULAR DRUGS AND THERAPY. 2022; 36(5)DOI:10.1007/s10557-021-07208-9. PMID:34251593. IF:3.400(Q2/5D).
01/07/2022 Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Gorog, DA, Storey, RF, Gurbel, PA, Tantry, US, Berger, JS, Chan, MY, Duerschmied, D, Smyth, SS, Parker, WAE, Ajjan, RA, Vilahur, G, Badimon, L, ten Berg, JM, ten Cate, H, Peyvandi, F, Wang, TT, Becker, RC. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nature Reviews Cardiology. 2022; 19(7)DOI:10.1038/s41569-021-00665-7. PMID:35027697. IF:49.600(Q1/1D).
01/12/2021 Dyslipidemia and aortic valve disease
Mata, P, Alonso, R, de Isla, LP, Badimon, L. Dyslipidemia and aortic valve disease. CURRENT OPINION IN LIPIDOLOGY. 2021; 32(6)DOI:10.1097/MOL.0000000000000794. PMID:34629429. IF:4.616(Q2/4D).
01/12/2021 One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
Chiva-Blanch, G, Bratseth, V, Laake, K, Arnesen, H, Solheim, S, Schmidt, EB, Badimon, L, Seljeflot, I. One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction. CLINICAL NUTRITION. 2021; 40(12)DOI:10.1016/j.clnu.2021.10.007. PMID:34742136. IF:7.643(Q1/2D).
01/08/2021 PCSK9 and LRP5 in macrophage lipid internalization and inflammation
Badimon, L, Luquero, A, Crespo, J, Pena, E, Borrell-Pages, M. PCSK9 and LRP5 in macrophage lipid internalization and inflammation. CARDIOVASCULAR RESEARCH. 2021; 117(9)DOI:10.1093/cvr/cvaa254. PMID:32991689. IF:14.239(Q1/1D).
01/08/2021 The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis
Badimon, L, Vilahur, G, Rocca, B, Patrono, C. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. CARDIOVASCULAR RESEARCH. 2021; 117(9)DOI:10.1093/cvr/cvab003. PMID:33484117. IF:14.239(Q1/1D).
01/08/2021 Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes
Giro, O, Jimenez, A, Pane, A, Badimon, L, Ortega, E, Chiva-Blanch, G. Extracellular vesicles in atherothrombosis and cardiovascular disease: Friends and foes. ATHEROSCLEROSIS. 2021; 330DOI:10.1016/j.atherosclerosis.2021.07.002. PMID:34256307. IF:6.851(Q1/2D).
01/08/2021 Smoking and sex differences in first manifestation of cardiovascular disease
Vasiljevic, Z, Scarpone, M, Bergami, M, Yoon, J, van der Schaar, M, Krljanac, G, Asanin, M, Davidovic, G, Simovic, S, Manfrini, O, Mickovski-Katalina, N, Badimon, L, Cenko, E, Bugiardini, R. Smoking and sex differences in first manifestation of cardiovascular disease. ATHEROSCLEROSIS. 2021; 330DOI:10.1016/j.atherosclerosis.2021.06.909. PMID:34233252. IF:6.851(Q1/2D).